Target intelligence / Profile preview

F-box protein 40 (FBXO40)

Target
FBXO40
Molecular classification
Ubiquitin ligase (E3 ligase) component, SCF (SKP1-CUL1-F-box protein) complex subunit, F-box protein family, FBXO (F-box only) subfamily
01

Overview

F-box protein 40 is a component of the SCF-type E3 ubiquitin ligase complex and is encoded by the FBXO40 gene in humans. It contains an approximately 40 amino acid F-box motif that mediates interaction with the SKP1 protein, enabling assembly of the SCF complex. FBXO40 serves as a substrate-recognition component, promoting the ubiquitination and subsequent degradation of specific protein targets, most notably insulin receptor substrate 1 (IRS1), which modulates the insulin-like growth factor 1 (IGF1) signaling pathway. Through this mechanism, FBXO40 can limit downstream IGF1 activity and may influence muscle and neuronal biology. Although the roles of F-box protein 40 in cancer and neurodegenerative disorders have been proposed based on broader family function, there is limited direct evidence linking FBXO40 to specific diseases, and it is not currently a validated therapeutic or diagnostic target.

Other names
FBXO40FBX40F-box protein 40
02

Mechanism of action

Not applicable. No drugs are known to target FBXO40 specifically.

03

Biological functions

Protein ubiquitinationProtein degradation via proteasomeRegulation of insulin-like growth factor 1 (IGF1) signaling (via ubiquitination of IRS1)Potential role in myogenesis (muscle differentiation)
04

Disease associations

Cancer (based on general F-box protein family roles in cancer; FBXO40-specific evidence is not strong)Autism spectrum disorder (genetic association)Juvenile-onset Parkinson's disease (genetic association)Other (possible association with neuromuscular and signaling defects, but not well characterized)

Beyond the preview

Go deeper on F-box protein 40 (FBXO40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on F-box protein 40 (FBXO40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call